Sevelamer Carbonate In vitro binding study for EMA submission [Regulatives / Guidelines]

posted by jansari  – India, 2022-05-27 20:54 (489 d 22:00 ago) – Posting: # 23029
Views: 958

Dear divyen,

We have already gone through this the same it's just before published regulatory not accept this PAR..

And it's very difficult to pass the study in this acceptance's very stringent range for sevelamer carbonate..and guidance doesn't provide any methodology like USFDA..

If you have any idea and submit sevelamer study in europe Market then please guide....

Thank you very much for your prompt reply and guidance...

Complete thread:

UA Flag
 Admin contact
22,763 posts in 4,775 threads, 1,627 registered users;
10 visitors (0 registered, 10 guests [including 5 identified bots]).
Forum time: 18:55 CEST (Europe/Vienna)

A little Learning is a dang’rous Thing;
Drink deep, or taste not the Pierian Spring:
There shallow Draughts intoxicate the Brain,
And drinking largely sobers us again.    Alexander Pope

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz